Holen Sie sich die Stockscreener-App
152.37
1.33%
-2.06
Handel nachbörslich:
151.05
-1.32
-0.87%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$154.43
Offen:
$155.34
24-Stunden-Volumen:
616.93K
Relative Volume:
0.59
Marktkapitalisierung:
$10.19B
Einnahmen:
$13.64B
Nettoeinkommen (Verlust:
$1.05B
KGV:
15.95
EPS:
9.555
Netto-Cashflow:
$1.31B
1W Leistung:
+0.11%
1M Leistung:
-2.51%
6M Leistung:
+14.68%
1J Leistung:
+1.43%
1-Tages-Spanne:
$152.23
$155.34
1-Wochen-Bereich:
$151.45
$157.18
52-Wochen-Spanne:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
152.37 | 10.32B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
467.83 | 105.49B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
188.00 | 16.68B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.21 | 12.32B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
200.41 | 11.66B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
182.10 | 11.24B | 17.36B | 1.51B | 849.25M | 23.15 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health - GlobeNewswire Inc.
Assenagon Asset Management Trims DaVita Stake - National Today
Assenagon Asset Management S.A. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita stock dips 1.49% as company promotes home dialysis benefits - Traders Union
Wedge Capital Management L L P NC Purchases 45,998 Shares of DaVita Inc. $DVA - MarketBeat
SG Americas Securities LLC Increases Stake in DaVita Inc. $DVA - MarketBeat
DaVita (FRA:TRL) PB Ratio : (As of Mar. 28, 2026) - gurufocus.com
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why DaVita Inc (DVA) Is Set to Outperform the Market: Insights i - GuruFocus
DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita tops chart as the only large-cap healthcare services name rated strong buy - msn.com
DaVita Inc. stock faces scrutiny amid dialysis sector reimbursement pressures and Medicare policy sh - AD HOC NEWS
Flexibility of a Home Dialysis Nurse - CSRwire
Nordea Investment Management AB Boosts Holdings in DaVita Inc. $DVA - MarketBeat
DaVita, Inc. Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
How Investors Are Reacting To DaVita (DVA) CKCC Savings And Value-Based Kidney Care Momentum - Sahm
Hedge Fund Moves: Can DaVita Inc continue delivering strong returnsGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - MSN
DaVita Stock: Is DVA Outperforming the Health Care Sector? - Yahoo Finance
DaVita Inc Stock (ISIN: US23804L1035) Gains on Value-Based Care Progress Amid Institutional Selling - AD HOC NEWS
DaVita reports progress in value-based kidney care programs By Investing.com - Investing.com Australia
DaVita’s Strong Operations Confront Debt Warning And Insider Selling Signals - Yahoo Finance
DaVita reports progress in value-based kidney care programs - Investing.com
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement - PR Newswire
Chart Watch: Will DaVita Inc stock benefit from M A2026 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Zacks Industry Outlook Features Quest Diagnostics, DaVita, Option Care Health, and Addus HomeCare - Bitget
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Zacks Investment Research
DaVita getting closer to key technical benchmark - MSN
DaVita (DVA) Backs R1 Therapeutics with Major Investment - GuruFocus
Zacks.com featured highlights include Strategic Education, Seanergy Maritime Holdings, DaVita and FirstEnergy - Yahoo Finance
Delta Global Management LP Buys New Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc Stock (ISIN: US23804L1035) Faces Headwinds Amid Dialysis Demand Shifts and Regulatory Scr - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. Trade Ideas — LS:897914 - TradingView
DaVita Stock Sits at $151 With Analysts Pointing to a $190 High Target - TIKR.com
DaVita Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
DaVita Inc. $DVA Shares Acquired by Doma Perpetual Capital Management LLC - MarketBeat
Aquatic Capital Management Boosts Stake in DaVita - National Today
Aquatic Capital Management LLC Acquires 40,333 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Berkshire Hathaway Inc - MarketBeat
Is DaVita (DVA) Pricing Reflect Its Strong Multi‑Year Share Performance And Cash Flow Outlook - simplywall.st
DVA (DaVita) Graham Number : $N/A (As of Dec. 2025) - GuruFocus
DaVita (DVA) and Jazz Pharmaceuticals (JAZZ) Lead with Strong Bu - GuruFocus
DaVita Inc Stock (ISIN: US23804L1035) Gains Momentum on Institutional Buying and Strong Guidance - AD HOC NEWS
Jim Cramer on DaVita: "Haven’t seen that stock do that well in this long" - MSN
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Te Ahumairangi Investment Management Ltd Has $9.10 Million Position in DaVita Inc. $DVA - MarketBeat
A Look At DaVita (DVA) Valuation As Analyst Concerns Clash With Bullish Ratings - simplywall.st
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):